Comerica Bank
NVAX icon

Comerica Bank’s Novavax NVAX Stock Holding History

Comerica Bank’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$679 Hold
101
– – ﹤0.01% 3614
2025
Q3 		$876 Buy
+101
New +$786 ﹤0.01% 3598
2025
Q2 		– Sell
-289
Closed -$1.85K – 3770
2025
Q1 		$1.85K Hold
289
– – ﹤0.01% 3493
2024
Q4 		$2.32K Buy
+289
New +$2.79K ﹤0.01% 3462
2024
Q1 		– Sell
-325
Closed -$1.56K – 3801
2023
Q4 		$1.56K Buy
325
+256
+371% +$1.57K ﹤0.01% 3569
2023
Q3 		$500 Buy
+69
New +$551 ﹤0.01% 3712
2021
Q4 		– Sell
-23,320
Closed -$3.14M – 2184
2021
Q3 		$3.14M Buy
23,320
+2,343
+11% +$516K 0.02% 984
2021
Q2 		$4.56M Buy
20,977
+12,842
+158% +$2.35M 0.03% 768
2021
Q1 		$1.69M Buy
8,135
+6,102
+300% +$1.22M 0.01% 1461
2020
Q4 		$258K Sell
2,033
-201
-9% -$21.4K ﹤0.01% 2178
2020
Q3 		$208K Buy
2,234
+103
+5% +$12.5K ﹤0.01% 2183
2020
Q2 		$312K Buy
+2,131
New +$81.5K ﹤0.01% 2039
2019
Q2 		– Sell
-646
Closed -$7K – 2304
2019
Q1 		$7K Hold
646
– – ﹤0.01% 2271
2018
Q4 		$28K Hold
646
– – ﹤0.01% 2257
2018
Q3 		$24K Hold
646
– – ﹤0.01% 2267
2018
Q2 		$18K Buy
646
+96
+17% +$3.25K ﹤0.01% 2271
2018
Q1 		$19K Buy
+550
New +$22.1K ﹤0.01% 2270
2014
Q2 		– Sell
-849
Closed -$77K – 2180
2014
Q1 		$77K Sell
849
-14
-2% -$1.56K ﹤0.01% 2237
2013
Q4 		$88K Buy
863
+244
+39% +$17.2K ﹤0.01% 2207
2013
Q3 		$39K Hold
619
– – ﹤0.01% 2573
2013
Q2 		$25K Buy
+619
New +$26.8K ﹤0.01% 2263

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Comerica Bank's NVAX Position: Q4 2025 in Review

Comerica Bank held its Novavax (NVAX) position steady in Q4 2025 at 101 shares worth $679. The position accounts for ﹤0.01% of the portfolio, ranked #3614.

Comerica Bank first reported a position in NVAX in Q2 2013 and has held it in 21 quarters since. The position peaked at $4.56M in Q2 2021. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • Comerica Bank held 101 shares of Novavax worth $679 as of Q4 2025.
  • Comerica Bank left its Novavax share count unchanged in Q4 2025.
  • Novavax made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3614 holding.
  • Comerica Bank first reported a position in Novavax in Q2 2013 and has held it in 21 quarters since.
  • Comerica Bank's Novavax position peaked at $4.56M in Q2 2021.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.